- Home
- ARQT vs SPHR Comparison
ARQT vs SPHR Comparison
Compare ARQT & SPHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARQT | SPHR |
|---|---|---|
| Founded | 2016 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.4B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | ARQT | SPHR |
|---|---|---|
| Price | $25.38 | $96.40 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 12 |
| Target Price | $25.00 | ★ $85.67 |
| AVG Volume (30 Days) | ★ 1.5M | 742.8K |
| Earning Date | 02-25-2026 | 03-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $317,929,000.00 | ★ $1,075,530,000.00 |
| Revenue This Year | $85.83 | $14.51 |
| Revenue Next Year | $30.72 | $10.26 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 129.21 | N/A |
| 52 Week Low | $11.13 | $23.89 |
| 52 Week High | $31.77 | $101.89 |
Technical Indicators
Market Signals| Indicator | ARQT | SPHR |
|---|---|---|
| Relative Strength Index (RSI) | 37.28 | 55.01 |
| Support Level | $25.51 | $92.69 |
| Resistance Level | $26.97 | $100.22 |
| Average True Range (ATR) | 1.08 | 3.85 |
| MACD | -0.15 | -0.50 |
| Stochastic Oscillator | 12.10 | 45.14 |
Price Performance
Historical ComparisonAbout ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.
About SPHR Sphere Entertainment Co.
Sphere Entertainment Co is a live entertainment and media company. The firm creates, writes, casts, produces, and tours shows and events. The group has two reportable segments which includeSphere and MSG Networks. Sphere is a next-generation entertainment medium, and MSG Networks operates two regional sports and entertainment networks, as well as a direct-to-consumer (DTC) and authenticated streaming product.